Finding a new drug and vaccine for emerging swine flu: What is the concept?

Biologics: Targets and Therapy

Volumn 3, Issue , 2009, Pages 377-383

  Wiwanitkit, Viroj ^a  

^a WIWANITKIT HOUSE   (Thailand)

Author keywords

Concept; Drug; Swine flu; Vaccine

Indexed keywords

EID: 73349142173     PISSN: 11775475     EISSN: 11775491     Source Type: Journal    
DOI: 10.2147/BTT.S5619     Document Type: Review

References (97)

1. Stamboulian D, Bonvehí PE, Nacinovich FM, Cox N. Influenza. Infect Dis Clin North Am. 2000;14(1):141-166.
2. Turkulov V, Madle-Samardzija N. Influenza-always present among us. Med Pregl. 2000;53(3-4):154-158.
3. Gapochko KG, Ogarkov VI. Experimental production of air-borne infections. Zh Mikrobiol Epidemiol Immunobiol. 1972;49(11):84-92.
4. Tatem AJ, Rogers DJ, Hay SI. Global transport networks and infectious disease spread. Adv Parasitol. 2006;62:293-343.
5. Grayson ML, Melvani S, Druce J, et al. Efficacy of soap and water and alcohol-based hand-rub preparations against live H1N1 influenza virus on the hands of human volunteers. Clin Infect Dis. 2009;48(3): 285-291.
6. Simberkoff MS, Santos MR. Prevention of community-acquired and nosocomial pneumonia. Curr Opin Pulm Med. 1996;2(3):228-235.
7. American Academy of Pediatrics Committee on Infectious Diseases. Infection prevention and control in pediatric ambulatory settings. Pediatrics. 2007;120(3):650-665.
8. Carter JM. Hand washing decreases risk of colds and flu. J Natl Med Assoc. 2002;94(2):A11.
9. Maeda Y, Horimoto T, Kawaoka Y. Classification and genome structure of influenza virus. Nippon Rinsho. 2003;61(11):1886-1891.
10. Juozapaitis M, Antoniukas L. Influenza virus. Medicina (Kaunas). 2007;43(12):919-929.
11. Dowdle WR, Coleman MT, Gregg MB. Natural history of influenza type A in the United States, 1957-1972. Prog Med Virol. 1974;17: 91-135.
12. Robinson RQ. Natural history of influenza since the introduction of the A2 strain. Prog Med Virol. 1964;6:82-110.
13. Cox NJ, Subbarao K. Influenza. Lancet. 1999;354(9186):1277-1282.
14. Easing the burden: the challenge of managing influenza. Am J Manag Care. 2000;6(5 Suppl):S276-S281.
15. Gausset MF, Casadebaig F, Guillaud-Bataille JM, Quemada N, Terra JL. Mortality of mentally ill patients. Review of the literature. Encephale. 1992;18(1):93-100.
16. Yoshikawa TT. Important infections in elderly persons. West J Med. 1981;135(6):441-445.
17. Westcar S, Chantler T. Influenza: an overview with a paediatric focus. Community Pract. 2007;80(12):37-39.
18. Alagiriswami A, Cheeseman SH. Influenza and HIV: case report and review of potential interactions. AIDS Patient Care STDS. 2001;15(11):561-565.
19. Ferdinands JM, Mannino DM. Obstructive lung disease models: what is valid? COPD. 2008;5(6):382-393.
20. Lansdown AB. Viral Infections and diseases of the heart. Prog Med Virol. 1978;24:70-113.
21. Rothberg MB, Haessler SD, Brown RB. Complications of viral influenza. Am J Med. 2008;121(4):258-264.
22. Bro-Jørgensen K, Samuelsson IS. Influenza. Consequences for health and prevention. Ugeskr Laeger. 1989;151(40):2570-2574.
23. Ruben FL, Cate TR. Influenza pneumonia. Semin Respir Infect. 1987;2(2):122-129.
24. Sano T. Influenza myocarditis and pericarditis. Nippon Rinsho. 2006; 64(10):1916-1920.
25. Moreno-Flagge N, Bayard V, Quirós E, Alonso T. Acute encephalitis. Neuropsychiatric manifestations as expression of influenza virus infection. Medicina (B Aires). 2009;69(1):121-126.
26. Nobusawa E. Influenza encephalopathy and encephalitis. No To Hattatsu. 2000;32(2):142-147.
27. Wehinger H. Reye syndrome (author's transl). Klin Padiatr. 1977;189(3):206-210.
28. Sullivan CJ, Jordan MC. Diagnosis of viral pneumonia. Semin Respir Infect. 1988;3(2):148-161.
29. Flewett TH. Rapid diagnosis of virus diseases. Br Med Bull. 1985;41(4):315-321.
30. Chaǐka NA, Gorbachev EN. Use of the sensitized latex agglutination reaction for diagnosing viral infections. Vopr Virusol. 1985;30(5): 516-523.
31. Turner PA, Rytel MW. Diagnosis and management of viral infections. Compr Ther. 1984;10(6):20-29.
32. Voller A, Bidwell DE, Bartlett A. ELISA techniques in virology. Lab Res Methods Biol Med. 1982;5:59-81.
33. Frank AL. Selected laboratory aspects of influenza surveillance. Yale J Biol Med. 1982;55(3-4):201-205.
34. Schmidt J, Brunnemann H, Stelzner A, Süss J, Kittlick M, Oehring H. Virological diagnostics of acute respiratory diseases. Z Erkr Atmungsorgane. 1980;154(1):18-35.
35. Oswald NC, Jones MC, Yealland SJ. A review of routine tests for respiratory viruses in hospital inpatients. Thorax. 1975;30(4): 361-366.
36. Rytel MW. Rapid diagnostic methods in infectious diseases. Adv Intern Med. 1975;20:37-60.
37. Hofmann H. Modern virus diagnostics. Wien Med Wochenschr. 1973;123(49):725-729.
38. Pereira HG. Influenza: antigenic spectrum. Prog Med Virol. 1969; 11:46-79.
39. Mikhailovich V, Gryadunov D, Kolchinsky A, Makarov AA, Zasedatelev A. DNA microarrays in the clinic: infectious diseases. Bioessays. 2008;30(7):673-682.
40. Vernet G. Use of molecular assays for the diagnosis of influenza. Expert Rev Anti Infect Ther. 2007;5(1):89-104.
41. Ciçek C, Bilgiç A. Current approaches to the clinical virologic diagnosis of viral respiratory tract infections. Mikrobiyol Bul. 2003;37(2-3): 195-204.
42. Ellis JS, Zambon MC. Molecular diagnosis of influenza. Rev Med Virol. 2002;12(6):375-389.
43. Takahashi H. Recent progress in the diagnosis of respiratory disease: respiratory infection. Rinsho Byori. 2000;48(12):1130-1135.
44. Huang LM. Recent advances in the study, prevention, and treatment of infectious diseases. J Formos Med Assoc. 2000;99(2):92-99.
45. Shaw MW, Arden NH, Maassab HF. New aspects of influenza viruses. Clin Microbiol Rev. 1992;5(1):74-92.
46. Harper SA, Bradley JS, et al. Seasonal influenza in adults and children-diagnosis, treatment, chemoprophylaxis, and institutional outbreak management: clinical practice guidelines of the Infectious Diseases Society of America. Clin Infect Dis. 2009;48(8):1003-1032.
47. Colman PM. New antivirals and drug resistance. Annu Rev Biochem. 2009;78:95-118.
48. Hayden F. Developing new antiviral agents for influenza treatment: what does the future hold? Clin Infect Dis. 2009;48(Suppl 1):S3-S13.
49. Colman PM. A novel approach to antiviral therapy for influenza. J Antimicrob Chemother. 1999;44(Suppl B):17-22.
50. Laustsen G, Wimett L. Drug approval highlights for 2003. Nurse Pract. 2004;29(2):8-15, 19-21.
51. Takeuchi Y. Amantadine. Nippon Rinsho. 2003;61(11):1967-1974.
52. Hannoun C. Rimantadine in the prevention and treatment of influenza A. Rev Med Interne. 1988;9(5):554-558.
53. Schirmer P, Holodniy M. Oseltamivir for treatment and prophylaxis of influenza infection. Expert Opin Drug Saf. 2009;8(3):357-371.
54. Oxford JS. Zanamivir (Glaxo Wellcome). Drugs. 2000;3(4): 447-459.
55. Cheer SM, Wagstaff AJ. Spotlight on zanamivir in influenza. Am J Respir Med. 2002;1(2):147-152.
56. Caballero E, Prieto C, Ruiz M, Azanza JR. Zanamivir: new therapeutic option for influenza. Rev Med Univ Navarra. 2000;44(1):56-61.
57. Wiwanitkit V. New respiratory virus (chicken pox, influenza and respiratory syncytial virus) vaccines: Efficacy, necessity and policy for tropical world at present. Hum Vaccin. 2009;5(9). [Epub ahead of print].
58. Jefferson T, Demicheli V. Influenza vaccination for elderly people and their care workers. Lancet. 2007;369(9576):1857-1858.
59. Jefferson TO, Rivetti D, Di Pietrantonj C, Rivetti A, Demicheli V. Vaccines for preventing influenza in healthy adults. Cochrane Database Syst Rev. 2007;2:CD001269.
60. Auewarakul P, Thongcharoen P. Vaccines for a potential influenza pandemic. Future Microbiol. 2007;2:345-349.
61. Forgie S, Marrie TJ. Healthcare-associated atypical pneumonia. Semin Respir Crit Care Med. 2009;30(1):67-85.
62. Kaji M. Influenza and other viral respiratory infections. Nippon Rinsho. 2003;61(11):1880-1885.
63. Cherkasskiǐ BL. New infections: myths and reality. Zh Mikrobiol Epidemiol Immunobiol. 2007;(3):111-116.
64. Jeeninga RE, de Jong MD, Berkhout B. The New Influenza A (H1N1) Pandemic. J Formos Med Assoc. 2009;108(7):523-525.
65. Chan PK. A review on human influenza A H5N1 infections in Hong Kong. Sci China C Life Sci. 2009;52(5):412-418.
66. Khanna M, Kumar P, Choudhary K, Kumar B, Vijayan VK. Emerging influenza virus: a global threat. J Biosci. 2008;33(4):475-482.
67. Holst PJ, Christensen JP, Thomsen AR. Avian influenza and perspectives on vaccination against pandemic influenza. Ugeskr Laeger. 2008;24;170(48):3953-3956.
68. Ong A, Kindhauser M, Smith I, Chan M. A global perspective on avian influenza. Ann Acad Med Singapore. 2008;37(6):477-481.
69. Lupiani B, Reddy SM. The history of avian influenza. Comp Immunol Microbiol Infect Dis. 2009;32(4):311-323.
70. Pappaioanou M. Highly pathogenic H5N1 avian influenza virus: cause of the next pandemic? Comp Immunol Microbiol Infect Dis. 2009;32(4):287-300.
71. Guery B, Guidet B, Beloucif S, et al. Organization of intensive care in situation of avian flu pandemic. Arch Pediatr. 2008;15(12): 1781-1793.
72. Wiwanitkit V. No evidence of gynecological and obstetrical manifestation in H5N1 influenza virus infection. Arch Gynecol Obstet. 2009;279(4):609.
73. Wiwanitkit V. Obstetrical concern on new emerging swine flu. Arch Gynecol Obstet. 2009; May 24. [Epub ahead of print].
74. Naffakh N, van der Werf S. April 2009: an outbreak of swine-origin influenza A(H1N1) virus with evidence for human-to-human transmission. Microbes Infect. 2009;11(8-9):725-728.
75. Wang TT, Palese P. Unraveling the mystery of swine influenza virus. Cell. 2009;137(6):983-985.
76. While A. Swine flu: some good lessons learnt. Br J Community Nurs. 2009;14(6):270-275.
77. Nava GM, Attene-Ramos MS, Ang JK, Escorcia M. Origins of the new influenza A(H1N1) virus: time to take action. Euro Surveill. 2009;14(22). pii:19228.
78. Hayden EC. Avian influenza aided readiness for swine flu. Nature. 2009;459(7248):756-757.
79. Silversides A. Swine flu outbreak tests Canadian preparedness. CMAJ. 2009;180(12):E93-E94.
80. Kuntz-Simon G, Madec F. Genetic and antigenic evolution of swine influenza viruses in Europe and evaluation of their zoonotic potential. Zoonoses Public Health. 2009; May 29. [Epub ahead of print].
81. Opal SM. Swine flu, pandemics, and critical care. Crit Care. 2009; 13(3):146.
82. Castledine G. Swine flu panic is being spread by ignorance. Br J Nurs. 2009;18(10):651.
83. Mossad SB. The resurgence of swine-origin influenza A (H1N1). Cleve Clin J Med. 2009;76(6):337-343.
84. Cohen J. Swine flu outbreak. New details on virus's promiscuous past. Science. 2009;324(5931):1127.
85. Butler D. Swine flu attention turns to the tropics. Nature. 2009; 459(7246):490-491.
86. Collin N, de Radiguès X, Kieny MP; the World Health Organization H1N1 Vaccine Task Force. New influenza A(H1N1) vaccine: How ready are we for large-scale production? Vaccine. 2009; Jun 26. [Epub ahead of print].
87. Garten RJ, Davis CT, Russell CA, et al. Antigenic and genetic characteristics of swine-origin 2009 A(H1N1) influenza viruses circulating in humans. Science. 2009;325(5937):197-201.
88. Couzin-Frankel J. Swine flu outbreak. What role for antiviral drugs? Science. 2009;324(5928):705.
89. Centers for Disease Control and Prevention (CDC). Update: drug susceptibility of swine-origin influenza A (H1N1) viruses, April 2009. MMWR Morb Mortal Wkly Rep. 2009;58(16):433-435.
90. Centers for Disease Control and Prevention (CDC). Update: swine influenza A (H1N1) infections-California and Texas, April 2009. MMWR Morb Mortal Wkly Rep. 2009;58(16):435-437.
91. Schirmer P, Holodniy M. Oseltamivir for treatment and prophylaxis of influenza infection. Expert Opin Drug Saf. 2009;8(3):357-371.
92. Wiwanitkit V. Antiviral drug treatment for emerging swine flu. Clin Ther. 2009;160(3):243-245.
93. Du QS, Wang SQ, Huang RB, Zhang DW, Chou KC. Insights from investigating the interaction of oseltamivir (Tamiflu) with neuraminidase of the 2009 H1N1 swine flu virus. Biochem Biophys Res Commun. 2009;386(3):432-436.
94. Maurer-Stroh S, Ma J, Lee RT, Sirota FL, Eisenhaber F. Mapping the sequence mutations of the 2009 H1N1 influenza A virus neuraminidase relative to drug and antibody binding sites. Biol Direct. 2009;4:18.
95. Enserink M, Kaiser J. Swine flu outbreak. Devilish dilemmas surround pandemic flu vaccine. Science. 2009;324(5928):702-705.
96. Baras B, Bouveret N, Devaster JM, et al. A vaccine manufacturer's approach to address medical needs related to seasonal and pandemic influenza viruses. Influenza Other Respi Viruses. 2008;2(6): 251-260.
97. Saville M, Marsh G, Hoffenbach A. Improving seasonal and pandemic influenza vaccines. Influenza Other Respi Viruses. 2008;2(6): 229-235.